Skip to Main Content

Paper Details

CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis.
Can J Cardiol
81
2020
Author NameAffiliation
David Z I CherneyUniversity Health Network, University of Toronto
Lee A GreenUniversity of Alberta
Adrian F HernandezDuke Clinical Research Institute
Frederick A MasoudiUniversity of Colorado Anschutz Medical Campus
  • 1 - 4

Datasets

Release 1.2